nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR2B—Raloxifene—breast cancer	0.226	1	CbGbCtD
Oxymetazoline—NISCH—mammary gland—breast cancer	0.0129	0.0713	CbGeAlD
Oxymetazoline—NISCH—nipple—breast cancer	0.0107	0.059	CbGeAlD
Oxymetazoline—NISCH—Paclitaxel—Docetaxel—breast cancer	0.00925	0.358	CbGdCrCtD
Oxymetazoline—HTR1E—female gonad—breast cancer	0.00661	0.0366	CbGeAlD
Oxymetazoline—NISCH—Vincristine—Vinorelbine—breast cancer	0.00636	0.246	CbGdCrCtD
Oxymetazoline—ADRA1D—epithelium—breast cancer	0.00599	0.0332	CbGeAlD
Oxymetazoline—NISCH—uterus—breast cancer	0.00593	0.0328	CbGeAlD
Oxymetazoline—NISCH—pituitary gland—breast cancer	0.00582	0.0322	CbGeAlD
Oxymetazoline—NISCH—adipose tissue—breast cancer	0.0058	0.0321	CbGeAlD
Oxymetazoline—NISCH—adrenal gland—breast cancer	0.0052	0.0288	CbGeAlD
Oxymetazoline—NISCH—Vinblastine—Vinorelbine—breast cancer	0.00512	0.198	CbGdCrCtD
Oxymetazoline—NISCH—Vincristine—Vinblastine—breast cancer	0.00508	0.197	CbGdCrCtD
Oxymetazoline—NISCH—bone marrow—breast cancer	0.00503	0.0279	CbGeAlD
Oxymetazoline—ADRA2C—nipple—breast cancer	0.00487	0.0269	CbGeAlD
Oxymetazoline—NISCH—female gonad—breast cancer	0.00485	0.0269	CbGeAlD
Oxymetazoline—ADRA1D—female reproductive system—breast cancer	0.00445	0.0246	CbGeAlD
Oxymetazoline—HTR2B—skin of body—breast cancer	0.00396	0.0219	CbGeAlD
Oxymetazoline—ADRA2A—nipple—breast cancer	0.00388	0.0215	CbGeAlD
Oxymetazoline—ADRA1D—endocrine gland—breast cancer	0.00376	0.0208	CbGeAlD
Oxymetazoline—HTR2B—endometrium—breast cancer	0.00373	0.0207	CbGeAlD
Oxymetazoline—HTR2B—uterus—breast cancer	0.00344	0.0191	CbGeAlD
Oxymetazoline—ADRA1A—epithelium—breast cancer	0.00344	0.019	CbGeAlD
Oxymetazoline—HTR1B—female reproductive system—breast cancer	0.00343	0.019	CbGeAlD
Oxymetazoline—HTR2B—adipose tissue—breast cancer	0.00337	0.0186	CbGeAlD
Oxymetazoline—HTR1D—female reproductive system—breast cancer	0.00333	0.0184	CbGeAlD
Oxymetazoline—HTR2C—female reproductive system—breast cancer	0.00329	0.0182	CbGeAlD
Oxymetazoline—NISCH—lymph node—breast cancer	0.00312	0.0173	CbGeAlD
Oxymetazoline—HTR2B—female reproductive system—breast cancer	0.00309	0.0171	CbGeAlD
Oxymetazoline—HTR2B—adrenal gland—breast cancer	0.00302	0.0167	CbGeAlD
Oxymetazoline—ADRA2C—endometrium—breast cancer	0.00294	0.0163	CbGeAlD
Oxymetazoline—HTR1B—endocrine gland—breast cancer	0.00291	0.0161	CbGeAlD
Oxymetazoline—ADRA1A—adipose tissue—breast cancer	0.00278	0.0154	CbGeAlD
Oxymetazoline—HTR2A—embryo—breast cancer	0.00272	0.0151	CbGeAlD
Oxymetazoline—ADRA2C—uterus—breast cancer	0.00271	0.015	CbGeAlD
Oxymetazoline—ADRA2C—pituitary gland—breast cancer	0.00266	0.0147	CbGeAlD
Oxymetazoline—ADRA2C—adipose tissue—breast cancer	0.00265	0.0147	CbGeAlD
Oxymetazoline—ADRA1A—adrenal gland—breast cancer	0.00249	0.0138	CbGeAlD
Oxymetazoline—ADRA2C—adrenal gland—breast cancer	0.00238	0.0132	CbGeAlD
Oxymetazoline—ADRA2A—endometrium—breast cancer	0.00234	0.013	CbGeAlD
Oxymetazoline—HTR2A—epithelium—breast cancer	0.00222	0.0123	CbGeAlD
Oxymetazoline—ADRA2C—female gonad—breast cancer	0.00222	0.0123	CbGeAlD
Oxymetazoline—ADRA1A—endocrine gland—breast cancer	0.00216	0.012	CbGeAlD
Oxymetazoline—ADRA2A—uterus—breast cancer	0.00216	0.012	CbGeAlD
Oxymetazoline—ADRA2A—pituitary gland—breast cancer	0.00212	0.0117	CbGeAlD
Oxymetazoline—ADRA2A—adipose tissue—breast cancer	0.00211	0.0117	CbGeAlD
Oxymetazoline—ADRA2A—female reproductive system—breast cancer	0.00194	0.0108	CbGeAlD
Oxymetazoline—ADRA2A—adrenal gland—breast cancer	0.0019	0.0105	CbGeAlD
Oxymetazoline—HTR2B—lymph node—breast cancer	0.00181	0.01	CbGeAlD
Oxymetazoline—HTR2A—pituitary gland—breast cancer	0.0018	0.00999	CbGeAlD
Oxymetazoline—ADRA2A—female gonad—breast cancer	0.00177	0.00979	CbGeAlD
Oxymetazoline—HTR2A—female reproductive system—breast cancer	0.00165	0.00915	CbGeAlD
Oxymetazoline—ADRA2A—endocrine gland—breast cancer	0.00164	0.0091	CbGeAlD
Oxymetazoline—HTR2A—adrenal gland—breast cancer	0.00161	0.00892	CbGeAlD
Oxymetazoline—ADRA2C—lymph node—breast cancer	0.00142	0.00789	CbGeAlD
Oxymetazoline—HTR2A—endocrine gland—breast cancer	0.0014	0.00774	CbGeAlD
Oxymetazoline—ADRA2A—lymph node—breast cancer	0.00114	0.00629	CbGeAlD
Oxymetazoline—HTR2C—GPCR downstream signaling—AKT1—breast cancer	1.98e-05	3.49e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EGFR—breast cancer	1.98e-05	3.48e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SRC—breast cancer	1.97e-05	3.47e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CTNNB1—breast cancer	1.97e-05	3.47e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NOS3—breast cancer	1.96e-05	3.46e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CXCL8—breast cancer	1.96e-05	3.46e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CASP3—breast cancer	1.96e-05	3.46e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL2—breast cancer	1.96e-05	3.45e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MAPK3—breast cancer	1.95e-05	3.44e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—HRAS—breast cancer	1.95e-05	3.44e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL6—breast cancer	1.95e-05	3.44e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CDKN1B—breast cancer	1.95e-05	3.43e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	1.93e-05	3.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MMP9—breast cancer	1.93e-05	3.4e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—AKT1—breast cancer	1.92e-05	3.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CDKN1A—breast cancer	1.92e-05	3.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—VEGFA—breast cancer	1.92e-05	3.38e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PTEN—breast cancer	1.92e-05	3.38e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	1.92e-05	3.38e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	1.91e-05	3.38e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	1.91e-05	3.37e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	1.91e-05	3.37e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCND1—breast cancer	1.91e-05	3.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CASP3—breast cancer	1.91e-05	3.36e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—KRAS—breast cancer	1.91e-05	3.36e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—JUN—breast cancer	1.9e-05	3.36e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL2—breast cancer	1.9e-05	3.36e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MDM2—breast cancer	1.9e-05	3.36e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—STAT3—breast cancer	1.9e-05	3.35e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MYC—breast cancer	1.9e-05	3.35e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RAF1—breast cancer	1.9e-05	3.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL6—breast cancer	1.89e-05	3.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	1.89e-05	3.34e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TGFB1—breast cancer	1.89e-05	3.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—KRAS—breast cancer	1.89e-05	3.34e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CTNNB1—breast cancer	1.89e-05	3.33e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RELA—breast cancer	1.89e-05	3.33e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CASP3—breast cancer	1.88e-05	3.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MAPK8—breast cancer	1.88e-05	3.31e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—ERBB2—breast cancer	1.88e-05	3.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL2—breast cancer	1.87e-05	3.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—AKT1—breast cancer	1.87e-05	3.3e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	1.87e-05	3.3e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—KRAS—breast cancer	1.87e-05	3.29e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL6—breast cancer	1.86e-05	3.29e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MDM2—breast cancer	1.86e-05	3.29e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RAF1—breast cancer	1.86e-05	3.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCND1—breast cancer	1.86e-05	3.27e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EGFR—breast cancer	1.86e-05	3.27e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MMP9—breast cancer	1.85e-05	3.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—JUN—breast cancer	1.85e-05	3.27e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MTOR—breast cancer	1.85e-05	3.26e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CB—breast cancer	1.85e-05	3.26e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RELA—breast cancer	1.85e-05	3.26e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CDKN1A—breast cancer	1.85e-05	3.26e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PTEN—breast cancer	1.84e-05	3.25e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CTNNB1—breast cancer	1.84e-05	3.24e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—ERBB2—breast cancer	1.84e-05	3.24e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCND1—breast cancer	1.83e-05	3.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NOS3—breast cancer	1.82e-05	3.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—JUN—breast cancer	1.82e-05	3.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MAPK3—breast cancer	1.82e-05	3.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MTOR—breast cancer	1.81e-05	3.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	1.81e-05	3.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.81e-05	3.19e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MMP9—breast cancer	1.8e-05	3.18e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MAPK8—breast cancer	1.8e-05	3.18e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—AKT1—breast cancer	1.8e-05	3.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CDKN1A—breast cancer	1.8e-05	3.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PTEN—breast cancer	1.79e-05	3.16e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CXCL8—breast cancer	1.78e-05	3.14e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SRC—breast cancer	1.78e-05	3.14e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MMP9—breast cancer	1.77e-05	3.13e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—HRAS—breast cancer	1.77e-05	3.12e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1.77e-05	3.12e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MYC—breast cancer	1.77e-05	3.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PTEN—breast cancer	1.76e-05	3.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TGFB1—breast cancer	1.76e-05	3.11e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—KRAS—breast cancer	1.75e-05	3.09e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MAPK8—breast cancer	1.75e-05	3.09e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PIK3CA—breast cancer	1.75e-05	3.09e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—AKT1—breast cancer	1.75e-05	3.08e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CXCL8—breast cancer	1.74e-05	3.07e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTEN—breast cancer	1.74e-05	3.07e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.74e-05	3.07e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CDKN1B—breast cancer	1.74e-05	3.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VEGFA—breast cancer	1.73e-05	3.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.73e-05	3.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HRAS—breast cancer	1.73e-05	3.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EGFR—breast cancer	1.73e-05	3.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.73e-05	3.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.73e-05	3.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.72e-05	3.03e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—AKT1—breast cancer	1.72e-05	3.03e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RELA—breast cancer	1.72e-05	3.03e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—STAT3—breast cancer	1.72e-05	3.03e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PIK3CA—breast cancer	1.71e-05	3.02e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SRC—breast cancer	1.71e-05	3.01e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.71e-05	3.01e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CASP3—breast cancer	1.7e-05	3e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	1.7e-05	3e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL2—breast cancer	1.7e-05	3e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—breast cancer	1.69e-05	2.99e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL6—breast cancer	1.69e-05	2.98e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.68e-05	2.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.68e-05	2.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.68e-05	2.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.67e-05	2.94e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL2—breast cancer	1.66e-05	2.94e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VEGFA—breast cancer	1.66e-05	2.93e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SRC—breast cancer	1.66e-05	2.93e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—breast cancer	1.66e-05	2.93e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCND1—breast cancer	1.66e-05	2.92e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.66e-05	2.92e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—JUN—breast cancer	1.65e-05	2.92e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—STAT3—breast cancer	1.65e-05	2.91e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CTNNB1—breast cancer	1.64e-05	2.89e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.64e-05	2.89e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SRC—breast cancer	1.64e-05	2.88e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—KRAS—breast cancer	1.63e-05	2.88e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.62e-05	2.86e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HRAS—breast cancer	1.62e-05	2.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—JUN—breast cancer	1.62e-05	2.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.62e-05	2.85e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.62e-05	2.85e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PIK3CA—breast cancer	1.61e-05	2.84e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MMP9—breast cancer	1.61e-05	2.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.61e-05	2.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.61e-05	2.83e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.6e-05	2.83e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.6e-05	2.83e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PTEN—breast cancer	1.6e-05	2.82e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MYC—breast cancer	1.59e-05	2.81e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.59e-05	2.81e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.59e-05	2.8e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HRAS—breast cancer	1.59e-05	2.8e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.58e-05	2.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.58e-05	2.78e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.58e-05	2.78e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.57e-05	2.78e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.57e-05	2.77e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.57e-05	2.76e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.56e-05	2.76e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.56e-05	2.76e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.56e-05	2.75e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.56e-05	2.75e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—breast cancer	1.56e-05	2.75e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL6—breast cancer	1.55e-05	2.74e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.55e-05	2.73e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL2—breast cancer	1.55e-05	2.73e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.54e-05	2.71e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.53e-05	2.7e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.53e-05	2.7e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MYC—breast cancer	1.53e-05	2.7e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.53e-05	2.7e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.53e-05	2.69e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL6—breast cancer	1.52e-05	2.68e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PIK3CA—breast cancer	1.51e-05	2.67e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.51e-05	2.66e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.51e-05	2.66e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—JUN—breast cancer	1.5e-05	2.65e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	1.5e-05	2.64e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EGFR—breast cancer	1.5e-05	2.64e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.49e-05	2.63e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HRAS—breast cancer	1.49e-05	2.63e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MYC—breast cancer	1.49e-05	2.63e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.49e-05	2.62e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SRC—breast cancer	1.48e-05	2.62e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.47e-05	2.6e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MYC—breast cancer	1.47e-05	2.58e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.46e-05	2.58e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.46e-05	2.58e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.46e-05	2.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.46e-05	2.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.46e-05	2.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SRC—breast cancer	1.45e-05	2.56e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—breast cancer	1.45e-05	2.56e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.44e-05	2.55e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.43e-05	2.53e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AKT1—breast cancer	1.43e-05	2.52e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—STAT3—breast cancer	1.43e-05	2.52e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL6—breast cancer	1.43e-05	2.52e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.42e-05	2.51e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.42e-05	2.5e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.41e-05	2.5e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—KRAS—breast cancer	1.41e-05	2.49e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.4e-05	2.47e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AKT1—breast cancer	1.4e-05	2.47e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HRAS—breast cancer	1.39e-05	2.45e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.38e-05	2.43e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.37e-05	2.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.35e-05	2.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.35e-05	2.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SRC—breast cancer	1.35e-05	2.38e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.34e-05	2.36e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MYC—breast cancer	1.33e-05	2.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL6—breast cancer	1.33e-05	2.34e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.33e-05	2.34e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AKT1—breast cancer	1.32e-05	2.32e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.31e-05	2.32e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—breast cancer	1.31e-05	2.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MYC—breast cancer	1.3e-05	2.3e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.3e-05	2.3e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EGFR—breast cancer	1.3e-05	2.29e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.3e-05	2.29e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.3e-05	2.29e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.27e-05	2.25e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.26e-05	2.23e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—breast cancer	1.26e-05	2.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.25e-05	2.21e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.24e-05	2.19e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.24e-05	2.19e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—AKT1—breast cancer	1.23e-05	2.18e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—KRAS—breast cancer	1.23e-05	2.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3CA—breast cancer	1.23e-05	2.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AKT1—breast cancer	1.22e-05	2.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—breast cancer	1.22e-05	2.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MYC—breast cancer	1.21e-05	2.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.21e-05	2.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—breast cancer	1.2e-05	2.12e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—KRAS—breast cancer	1.2e-05	2.12e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HRAS—breast cancer	1.2e-05	2.12e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL6—breast cancer	1.2e-05	2.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.18e-05	2.09e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HRAS—breast cancer	1.17e-05	2.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HRAS—breast cancer	1.15e-05	2.03e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL6—breast cancer	1.15e-05	2.03e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.13e-05	1.99e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL6—breast cancer	1.12e-05	1.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.12e-05	1.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKT1—breast cancer	1.11e-05	1.95e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.11e-05	1.95e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL6—breast cancer	1.1e-05	1.94e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—breast cancer	1.09e-05	1.93e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—breast cancer	1.07e-05	1.89e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKT1—breast cancer	1.06e-05	1.87e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HRAS—breast cancer	1.04e-05	1.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKT1—breast cancer	1.03e-05	1.82e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.03e-05	1.81e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.02e-05	1.8e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.02e-05	1.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—AKT1—breast cancer	1e-05	1.77e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL6—breast cancer	9.99e-06	1.76e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—breast cancer	9.93e-06	1.75e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL6—breast cancer	9.79e-06	1.73e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HRAS—breast cancer	9.5e-06	1.68e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKT1—breast cancer	9.22e-06	1.63e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL6—breast cancer	9.09e-06	1.6e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKT1—breast cancer	9.03e-06	1.59e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKT1—breast cancer	8.39e-06	1.48e-05	CbGpPWpGaD
